gilteritinib maintenance after allogeneic transplantation in flt3-mutated aml
Published 1 year ago • 283 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
1:33
the use of gilteritinib in post-transplant maintenance for aml with flt3-itd
-
1:43
lba: gilteritinib as post-transplant maintenance therapy in flt3-itd aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
5:09
morpho: gilteritinib as post-transplant maintenance therapy in patients with flt3-itd aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
2:15
real-world analysis of gilteritinib for r/r flt3-mutated aml
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
43:10
venetoclax plus gilteritinib for flt3-mutated relapsed/refractory acute myeloid leukemia
-
6:38
gilteritinib plus venetoclax for r/r flt3-mutated aml
-
1:23
the promise of combining venetoclax with gilteritinib for the treatment of flt3-mutated aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
4:47
commodore: gilteritinib for the treatment of r/r flt3-mutated aml
-
1:35
flt3 inhibitor maintenance after allo-sct for aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
2:29
flt3 inhibitors as maintenance therapy in aml
-
1:33
is gilteritinib the new breakthrough in the treatment of flt3-mutated aml?
-
2:35
gilteritinib, venetoclax, low-dose cytarabine, and actinomycin d in flt3-mutated aml
-
3:01
admiral: gilteritinib for r/r flt3-mutated aml
-
2:46
role of flt3 inhibitors as maintenance following transplant in aml